C. AMARA: Open Payments
NPI 1942265509 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,088 in 113 payments from 16 companies in 2025. Trend: 2023 $1,358 · 2024 $1,847 · 2025 $2,088
Food & beverage: $2,088
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $282 |
| Vanda Pharmaceuticals Inc. | 9 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $224 |
| Neurocrine BioSciences, Inc. | 10 | $222 |
| Teva Pharmaceuticals USA, Inc. | 13 | $169 |
| Janssen Pharmaceuticals, Inc | 8 | $155 |
| Otsuka America Pharmaceutical, Inc. | 10 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $141 |
| Lundbeck LLC | 5 | $90 |
| Alkermes, Inc. | 4 | $84 |
Products named: COBENFY, FANAPT, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, TRINTELLIX, SPRAVATO, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
